Nexgard Spectra RSS Authorised This medicine is authorised for use in the European Union afoxolaner / milbemycin oximeMedicineVeterinaryAuthorised
Page contentsPage contents Overview Product information Product details Authorisation details Assessment history News on Nexgard Spectra Topics Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Nexgard Spectra : EPAR - Medicine overview English (EN) (81.94 KB - PDF)First published: 10/02/2015 Last updated: 13/06/2024 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View español (ES) (81.97 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View čeština (CS) (93.99 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View dansk (DA) (83.34 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View Deutsch (DE) (82.76 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View eesti keel (ET) (82.18 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View ελληνικά (EL) (93.76 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View français (FR) (82.44 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View hrvatski (HR) (92.27 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View íslenska (IS) (83.29 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View Gaeilge (GA) (83.57 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View italiano (IT) (82.29 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View latviešu valoda (LV) (94.29 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View magyar (HU) (94.15 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View Malti (MT) (95.95 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View Nederlands (NL) (82.05 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View norsk (NO) (82 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View polski (PL) (95.62 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View português (PT) (83.01 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View română (RO) (94.17 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View slovenčina (SK) (94.08 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View slovenščina (SL) (82.27 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View Suomi (FI) (81.54 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View svenska (SV) (82.05 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View Product information Nexgard Spectra : EPAR - Product Information English (EN) (81.49 KB - PDF)First published: 10/02/2015 Last updated: 13/06/2024 View Other languages (25) български (BG) (91.78 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View español (ES) (81.51 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View čeština (CS) (92.48 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View dansk (DA) (82.05 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View Deutsch (DE) (81.72 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View eesti keel (ET) (81.22 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View ελληνικά (EL) (91.79 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View français (FR) (81.63 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View hrvatski (HR) (91.56 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View íslenska (IS) (81.52 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View Gaeilge (GA) (81.36 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View italiano (IT) (81.76 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View latviešu valoda (LV) (92.14 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View lietuvių kalba (LT) (92.19 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View magyar (HU) (92.76 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View Malti (MT) (93.86 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View Nederlands (NL) (81.15 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View norsk (NO) (81.52 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View polski (PL) (93.22 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View português (PT) (82.53 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View română (RO) (91.73 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View slovenčina (SK) (81.75 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View slovenščina (SL) (81.76 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View Suomi (FI) (81.11 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View svenska (SV) (81.47 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View Nexgard Spectra : EPAR - All Authorised presentations English (EN) (81.94 KB - PDF)First published: 10/02/2015 Last updated: 13/06/2024 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View español (ES) (81.97 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View čeština (CS) (93.99 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View dansk (DA) (83.34 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View Deutsch (DE) (82.76 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View eesti keel (ET) (82.18 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View ελληνικά (EL) (93.76 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View français (FR) (82.44 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View hrvatski (HR) (92.27 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View íslenska (IS) (83.29 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View Gaeilge (GA) (83.57 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View italiano (IT) (82.29 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View latviešu valoda (LV) (94.29 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View magyar (HU) (94.15 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View Malti (MT) (95.95 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View Nederlands (NL) (82.05 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View norsk (NO) (82 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View polski (PL) (95.62 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View português (PT) (83.01 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View română (RO) (94.17 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View slovenčina (SK) (94.08 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View slovenščina (SL) (82.27 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View Suomi (FI) (81.54 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View svenska (SV) (82.05 KB - PDF) First published: 10/02/2015 Last updated: 13/06/2024 View Product details Name of medicine Nexgard Spectra Active substance afoxolanermilbemycin oxime International non-proprietary name (INN) or common name afoxolanermilbemycin oxime Pharmacotherapeutic groupEndectocidesAntiparasitic products, insecticides and repellentsmilbemycin oxime, combinations Authorisation details EMA product number EMEA/V/C/003842 Assessment history Expand section Collapse section Changes since initial authorisation of medicine Nexgard Spectra : EPAR - Procedural steps taken and scientific information after authorisation English (EN) (81.94 KB - PDF)First published: 13/07/2017 Last updated: 13/06/2024 View CVMP post-authorisation summary of positive opinion for NexGard Spectra (VRA0000245082)Adopted Reference Number: EMADOC-1700519818-2201538 English (EN) (149.88 KB - PDF)First published: 13/06/2025 View CVMP post-authorisation summary of positive opinion for Nexgard Spectra (WS)Adopted Reference Number: EMA/CVMP/924541/2022 English (EN) (139.33 KB - PDF)First published: 09/12/2022 View Nexgard Spectra-V-C-3842-II-0019: Assessment report - VariationAdopted English (EN) (81.49 KB - PDF)First published: 15/10/2019 Last updated: 13/06/2024 View Nexgard Spectra-V-C-3842-WS-1559 : Assessment report - VariationAdopted English (EN) (81.49 KB - PDF)First published: 15/10/2019 Last updated: 13/06/2024 View CVMP post-authorisation summary of positive opinion for NexGard Spectra ; NexGardAdopted Reference Number: EMA/CVMP/369028/2019 English (EN) (113.4 KB - PDF)First published: 19/07/2019 View CVMP post-authorisation summary of positive opinion for Nexgard Spectra (II-0019)Adopted Reference Number: EMA/CVMP/369202/2019 English (EN) (112.1 KB - PDF)First published: 19/07/2019 View Nexgard Spectra-V-C-3842-WS-1338-G : EPAR - Assessment report - Variation English (EN) (81.49 KB - PDF)First published: 10/12/2018 Last updated: 13/06/2024 View CVMP post-authorisation summary of positive opinion for Nexgard SpectraAdopted Reference Number: EMA/CVMP/525858/2018 English (EN) (70.42 KB - PDF)First published: 14/09/2018 Last updated: 14/09/2018 View Nexgard Spectra-V-C-3842-II-0008 : EPAR - Assessment Report - VariationAdopted English (EN) (81.49 KB - PDF)First published: 13/07/2017 Last updated: 13/06/2024 View Initial marketing authorisation documents Nexgard Spectra : EPAR - Public assessment reportAdopted English (EN) (81.49 KB - PDF)First published: 10/02/2015 Last updated: 13/06/2024 View CVMP summary of positive opinion for Nexgard SpectraAdopted Reference Number: EMA/CVMP/641766/2014 English (EN) (69.3 KB - PDF)First published: 07/11/2014 Last updated: 07/11/2014 View News on Nexgard Spectra Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 2-4 December 202505/12/2025 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 June 202513/06/2025 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 3-5 October 202306/10/2023 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 5-7 September 202308/09/2023 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 6-8 December 202209/12/2022 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-13 April 202219/04/2022 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 8-9 September 202011/09/2020 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 3-5 December 201906/12/2019 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 10-12 September 201913/09/2019 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 16-18 July 201919/07/2019 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 22-24 January 201925/01/2019 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 11-13 September 201814/09/2018 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 16-18 January 201819/01/2018 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 5–7 September 201708/09/2017 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 13-15 June 201716/06/2017 Committee for Medicinal Products for Veterinary Use (CVMP) Meeting of 14-16 March 201717/03/2017 Committee for Medicinal Products for Veterinary Use (CVMP) meeting 6-8 December 201609/12/2016 Committee for Medicinal Products for Veterinary Use (CVMP) Meeting of 14-16 June 201617/06/2016 Committee for Medicinal Products for Veterinary Use (CVMP) Meeting of 8-10 December 201511/12/2015 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 8-10 September 201511/09/2015 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 4-6 November 201407/11/2014 Topics Medicines This page was last updated on 02/09/2025 Share this page